Austrianni GmbH is a new biotechnology company founded in 2015. Its mission is to develop novel antibody-based therapeutics for the prevention and treatment of tuberculosis and other important infectious diseases. Tuberculosis represents a major global health concern that kills more than a million people each year and significantly incapacitates up to ten times more than this. While it is currently most prevalent in low-income countries, cases arise everywhere. Drug-resistant forms of the disease are a major emergent concern especially in Central Asia and Eastern Europe, but the potential for these to become even more widespread is substantial. Despite decades of concerted research, no effective vaccine for tuberculosis has yet been developed, and the most widely used drugs to treat it remain limited by toxicity and other problems.
View Top Employees from Austrianni GmbHWebsite | http://www.austrianni.com |
Revenue | $5 million |
Employees | View employees |
Address | 6 Dr.-Bohr-Gasse 7, Vienna, Vienna, AT |
Phone | (431) 226-0075 |
Industry | Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Austrianni GmbH employee's phone or email?
The Austrianni GmbH annual revenue was $5 million in 2024.
Austrianni GmbH is based in Vienna, Vienna.
The NAICS codes for Austrianni GmbH are [325, 32541, 32, 3254].
The SIC codes for Austrianni GmbH are [283, 28].